Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Peripheral Modulation of Muscle Stiffness and Spasticity

Trial Profile

Peripheral Modulation of Muscle Stiffness and Spasticity

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Jan 2019

At a glance

  • Drugs Hyaluronidase (Primary)
  • Indications Muscle spasticity
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jan 2019 Planned initiation date changed from 1 Dec 2018 to 1 Jun 2019.
    • 08 Oct 2018 Planned initiation date changed from 1 Jun 2018 to 1 Dec 2018.
    • 26 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top